<code id='C4B3283257'></code><style id='C4B3283257'></style>
    • <acronym id='C4B3283257'></acronym>
      <center id='C4B3283257'><center id='C4B3283257'><tfoot id='C4B3283257'></tfoot></center><abbr id='C4B3283257'><dir id='C4B3283257'><tfoot id='C4B3283257'></tfoot><noframes id='C4B3283257'>

    • <optgroup id='C4B3283257'><strike id='C4B3283257'><sup id='C4B3283257'></sup></strike><code id='C4B3283257'></code></optgroup>
        1. <b id='C4B3283257'><label id='C4B3283257'><select id='C4B3283257'><dt id='C4B3283257'><span id='C4B3283257'></span></dt></select></label></b><u id='C4B3283257'></u>
          <i id='C4B3283257'><strike id='C4B3283257'><tt id='C4B3283257'><pre id='C4B3283257'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:knowledge    Page View:3824
          Tome cofounders Jonathan Gootenberg, left, and Omar Abudayyeh, a scientific team that's trying to reinvent gene editing for a new era of biotech innovation.
          Suzanne Kreiter/Globe staff

          WATERTOWN — Their brainstorming began in an MIT class in 2010 when the eager undergrads shot each other emails about how to solve a bioengineering equation. It has continued for 14 years over sushi dinners, between Marvel movies, and during rowing-machine workouts.

          Together, Omar Abudayyeh, 33, and Jonathan Gootenberg, 32, have probed the mysteries of genomic editing and COVID detection. They co-published 10 scientific papers, helped launch two medical-diagnostic companies, and cofounded a Watertown startup, Tome Biosciences, that reengineers genes and cells to cure diseases. They also run the Abudayyeh-Gootenberg Lab at Harvard.

          advertisement

          Gootenberg and Abudayyeh are an unusual pair, two scientists — a Jewish American and a Palestinian American — who prefer working together in a field that often draws solitary researchers and rewards individual achievement.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Duchenne breakthrough therapy leaves behind pioneering families
          Duchenne breakthrough therapy leaves behind pioneering families

          DuchennemusculardystrophyDr.EdwinP.Ewing,Jr./CDCPatFurlongwassittinginherhomeofficeinMiddletown,Ohio

          read more
          Sen. Paul opposes bill to ban Chinese biotechs
          Sen. Paul opposes bill to ban Chinese biotechs

          Sen.RandPaul(R-Ky.)WinMcNamee/GettyImagesWASHINGTON—ASenatepanelWednesdaypassedabillaimedatpreventin

          read more
          Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
          Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

          AdobeSometimes,anappleadayreallyisjustwhatthedoctorordered.Andforthepastseveralyears,organizationsli

          read more

          NEJM study link tiny plastics in blood vessels to heart problems

          DESIREEMARTIN/AFPviaGettyImagesMicroandnanoplastics,tinypiecesofplasticscatteredthroughouttheenviron